Impacts of a Physical Therapy Protocol on Motor Function in Children With Congenital Zika Syndrome
Launched by GABRIELA LOPES GAMA · Mar 27, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children with confirmed CZS diagnosis by RT-PCR or presumed by imaging findings (CT or MRI \[or both\]), and according to the Center for Disease Control and Prevention criteria
- • Children accompanied by the support center where the study was conducted.
- Exclusion Criteria:
- • Children who did not undergo assessments after the intervention
- • Children those weighing \< 9,600 kg, with uncontrolled seizures, or orthopedic changes (e.g., hip subluxations or dysplasia, severe spasticity combined with joint contractures, and severe scoliosis \[Cobb angle \> 40°\]).
About Gabriela Lopes Gama
Gabriela Lopes Gama is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, she leads initiatives that prioritize ethical standards, regulatory compliance, and participant safety. Gabriela's extensive experience in clinical trial management encompasses diverse therapeutic areas, and she collaborates closely with research institutions and healthcare professionals to ensure the successful design and execution of trials. Her proactive approach fosters a culture of transparency and collaboration, contributing to the advancement of science and the development of new treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Campina Grande, Paraíba, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported